These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12603500)

  • 1. Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment.
    Usta M; Ersoy A; Dilek K; Ozdemir B; Yavuz M; Güllülü M; Yurtkuran M
    J Intern Med; 2003 Mar; 253(3):329-34. PubMed ID: 12603500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.
    Lieberman KV; Tejani A
    J Am Soc Nephrol; 1996 Jan; 7(1):56-63. PubMed ID: 8808110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure.
    Mora-Macía J; Cases A; Calero F; Barceló P
    Nephrol Dial Transplant; 2001; 16 Suppl 1():82-4. PubMed ID: 11369829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional excretion of high- and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosis.
    Deegens JK; Wetzels JF
    Clin Nephrol; 2007 Oct; 68(4):201-8. PubMed ID: 17969486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of losartan treatment on the proteinuria in normotensive patients having proteinuria due to secondary amyloidosis.
    Odabas AR; Cetinkaya R; Selcuk Y; Bilen H
    Ups J Med Sci; 2001; 106(3):183-8. PubMed ID: 12166510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic.
    Stiles KP; Abbott KC; Welch PG; Yuan CM
    Clin Nephrol; 2001 Aug; 56(2):89-95. PubMed ID: 11522100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
    Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
    J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.
    Trachtman H; Vento S; Herreshoff E; Radeva M; Gassman J; Stein DT; Savin VJ; Sharma M; Reiser J; Wei C; Somers M; Srivastava T; Gipson DS
    BMC Nephrol; 2015 Jul; 16():111. PubMed ID: 26198842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse methylprednisolone, cyclosporine, and ace inhibitor therapy decreases proteinuria in two siblings with familial focal segmental glomerulosclerosis.
    Yorgin PD; Belson A; Higgins J; Alexander SR
    Am J Kidney Dis; 2001 Jun; 37(6):E44. PubMed ID: 11382715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy, Proteinuria, Plant-Based Supplemented Diets and Focal Segmental Glomerulosclerosis: A Report on Three Cases and Critical Appraisal of the Literature.
    Attini R; Leone F; Montersino B; Fassio F; Minelli F; Colla L; Rossetti M; Rollino C; Alemanno MG; Barreca A; Todros T; Piccoli GB
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28753930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation.
    Holgado R; Anaya F; Del Castillo D
    Nephrol Dial Transplant; 2001; 16 Suppl 1():117-20. PubMed ID: 11369838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of losartan on proteinuria and renal function in patients with renal amyloidosis.
    Dilek K; Usta M; Ersoy A; Ozdemir B; Yavuz M; Güllülü M; Yurtkuran M
    Scand J Urol Nephrol; 2002; 36(6):443-6. PubMed ID: 12623509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
    Heering P; Braun N; Müllejans R; Ivens K; Zäuner I; Fünfstück R; Keller F; Krämer BK; Schollmeyer P; Risler T; Grabensee B;
    Am J Kidney Dis; 2004 Jan; 43(1):10-8. PubMed ID: 14712422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.
    Praga M; Andrade CF; Luño J; Arias M; Poveda R; Mora J; Prat MV; Rivera F; Galceran JM; Ara JM; Aguirre R; Bernis C; Marín R; Campistol JM
    Nephrol Dial Transplant; 2003 Sep; 18(9):1806-13. PubMed ID: 12937228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
    Hari P; Bagga A; Jindal N; Srivastava RN
    Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
    Soliman AR; Maamoun H; Soliman H; Ahmed RM
    Rom J Intern Med; 2021 Jun; 59(2):127-133. PubMed ID: 33565308
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria.
    Huang J; Lin L; Xie J; Li X; Shen P; Pan X; Ren H; Chen N
    Clin Exp Nephrol; 2018 Dec; 22(6):1315-1323. PubMed ID: 29761241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.